Survodutide
$165.00
Survodutide is an investigational peptide that acts as a dual agonist of the glucagon receptor (GCGR) and the GLP‑1 receptor (GLP‑1R). Developed by Boehringer Ingelheim and Zealand Pharma, it has been studied in preclinical and early clinical models to explore its effects on metabolism, including energy balance and body weight regulation. Research has focused on its potential in obesity and metabolic dysfunction-associated steatohepatitis (MASH), with ongoing studies examining how it works at the molecular and cellular level.
For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.
Frequently Bought Together
Description
Survodutide is an investigational dual receptor agonist studied extensively in laboratory research for its activity at the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R). As a synthetic bioactive peptide, Survodutide is commonly investigated in preclinical and clinical research models exploring metabolic regulation, cellular signaling, energy homeostasis, and liver-related metabolic pathways.
This research compound is supplied for qualified laboratory use only and is intended for controlled in-vitro and preclinical research applications. Survodutide provides researchers with a valuable tool for studying dual receptor signaling, metabolic pathway interactions, and peptide-mediated cellular communication.
For Research Use Only. This product is not a drug, dietary supplement, cosmetic ingredient, or veterinary product. It is not intended for human or animal administration.
What Is Survodutide?
Survodutide is a synthetic investigational peptide that functions as a dual agonist of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R). It has been developed to investigate how simultaneous activation of these receptors influences metabolic signaling pathways and cellular energy regulation.
Research involving Survodutide focuses on understanding receptor-mediated mechanisms associated with glucose metabolism, lipid metabolism, energy balance, and intracellular signaling. Because of its dual receptor activity, Survodutide has become an important research compound in studies involving obesity, metabolic dysfunction-associated steatohepatitis (MASH), and endocrine biology.
Product Overview
| Specification | Details |
| Product Name | Survodutide |
| Category | Research Peptide |
| Classification | Dual GCGR/GLP-1R Agonist |
| Research Focus | Metabolic signaling, endocrine biology, energy homeostasis |
| Form | Lyophilized Powder |
| Intended Use | Laboratory Research Only |
Mechanism of Action Research
Dual Receptor Signaling
Survodutide primarily interacts with the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R), both of which are involved in regulating metabolic signaling pathways.
Laboratory studies investigate how dual receptor activation influences intracellular signaling, cellular metabolism, and physiological regulatory mechanisms.
Metabolic Pathway Research
Researchers study Survodutide to better understand signaling pathways involved in glucose utilization, lipid metabolism, and energy homeostasis.
Experimental models explore how coordinated receptor activation affects cellular metabolic responses and molecular communication.
Endocrine Research
Survodutide has been investigated in laboratory models examining hormone-mediated signaling and metabolic regulation.
Research focuses on understanding receptor interactions and downstream cellular pathways involved in endocrine physiology.
Research Applications
Metabolic Research
Survodutide is frequently used in laboratory studies investigating metabolic signaling pathways, energy regulation, and cellular metabolism.
Scientists utilize the peptide to examine receptor-mediated mechanisms under controlled experimental conditions.
Obesity Research Models
Preclinical and clinical research has investigated Survodutide in obesity-related models to better understand receptor biology and metabolic regulation.
These studies focus on molecular mechanisms rather than therapeutic outcomes.
Liver and MASH Research
Survodutide has also been studied in research involving metabolic dysfunction-associated steatohepatitis (MASH) and liver metabolism.
Laboratory investigations examine how dual receptor activation may influence cellular pathways involved in hepatic metabolism and tissue biology.
Endocrine and Cellular Biology
Researchers continue to investigate Survodutide for its effects on hormone signaling pathways, receptor interactions, and intracellular communication across various biological systems.
Key Research Areas of Survodutide
Survodutide research has focused on several areas, including:
- Dual GCGR and GLP-1R receptor signaling
- Metabolic pathway regulation
- Cellular energy homeostasis
- Endocrine signaling mechanisms
- Obesity research models
- MASH research
- Molecular signaling studies
These applications are limited to laboratory and preclinical research environments.
Quality and Research Standards
High-quality Survodutide products should meet strict research standards to ensure consistency and reliability.
Important quality considerations include:
- Verified peptide identity
- Analytical purity testing
- Proper laboratory packaging
- Controlled storage conditions
- Batch documentation when available
Researchers should always review analytical documentation before conducting laboratory investigations.
Storage and Handling Information
Survodutide should be stored according to recommended laboratory procedures to maintain stability.
Recommended handling practices include:
- Store lyophilized peptide under appropriate temperature-controlled conditions
- Protect from moisture and direct light
- Use sterile laboratory techniques during preparation
- Avoid repeated freeze-thaw cycles after reconstitution
Proper storage and handling help preserve peptide integrity for research applications.
Why Choose Survodutide for Research?
Researchers looking to buy Survodutide require a dependable research compound suitable for controlled laboratory investigations. Survodutide provides a valuable research model for studying dual receptor activation, metabolic signaling, and endocrine pathway interactions.
With applications across metabolic research, endocrinology, and cellular biology, Survodutide continues to support scientific investigations into complex biological signaling mechanisms.
Frequently Asked Questions
What is Survodutide used for in research?
Survodutide is studied in laboratory research involving dual receptor signaling, metabolic pathways, endocrine biology, and cellular communication mechanisms.
What receptors does Survodutide target?
Survodutide is investigated as a dual agonist of the glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R).
Is Survodutide approved for human use?
No. Survodutide is an investigational research compound and is supplied strictly for laboratory research purposes. It is not intended for human or animal administration or therapeutic use.
How is Survodutide studied?
Researchers investigate Survodutide using controlled laboratory models, including biochemical assays, cellular research systems, preclinical studies, and clinical research designed to better understand its biological mechanisms.
Is Survodutide a dietary supplement?
No. Survodutide is a research peptide intended solely for scientific investigation and is not a dietary supplement or consumer product.
Related products
-
Burn Blend
$200.00 Select options This product has multiple variants. The options may be chosen on the product page -
Tirz Research Peptide
$75.00 – $700.00Price range: $75.00 through $700.00 Select options This product has multiple variants. The options may be chosen on the product page -
Epithalon
$50.00 Select options This product has multiple variants. The options may be chosen on the product page -
MOTS-C Peptide
$55.00 – $480.00Price range: $55.00 through $480.00 Select options This product has multiple variants. The options may be chosen on the product page





